{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:17:01Z","timestamp":1738819021988,"version":"3.37.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00108-024-01842-9","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T13:21:03Z","timestamp":1737379263000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update Z\u00f6liakie","Celiac disease: an update"],"prefix":"10.1007","volume":"66","author":[{"given":"Helga Paula","family":"T\u00f6r\u00f6k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Koletzko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"1842_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jama.2019.10329","volume":"322","author":"CA Aronsson","year":"2019","unstructured":"Aronsson\u00a0CA, Lee\u00a0H\u2011S, Af Segerstad\u00a0EMH et\u00a0al (2019) Association of gluten intake during the first 5\u00a0years of life with incidence of celiac disease autoimmunity and celiac disease among children at increased risk. JAMA 322:514\u2013523","journal-title":"JAMA"},{"key":"1842_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S2213-8587(23)00354-6","volume":"12","author":"E Bosi","year":"2024","unstructured":"Bosi\u00a0E, Catassi\u00a0C (2024) Screening type\u00a01 diabetes and celiac disease by law. Lancet Diabetes Endocrinol 12:12\u201314","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1842_CR3","doi-asserted-by":"crossref","unstructured":"Bozorg SR, Lee A, Marild K et\u00a0al (2024) The Economic Iceberg of Celiac Disease: More Than the Cost of Gluten-Free Food. Gastroenterology","DOI":"10.1053\/j.gastro.2024.02.051"},{"key":"1842_CR4","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/S0140-6736(22)00794-2","volume":"399","author":"C Catassi","year":"2022","unstructured":"Catassi\u00a0C, Verdu\u00a0EF, Bai\u00a0JC et\u00a0al (2022) Coeliac disease. Lancet 399:2413\u20132426","journal-title":"Lancet"},{"key":"1842_CR5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S2468-1253(23)00205-4","volume":"8","author":"C Ciacci","year":"2023","unstructured":"Ciacci\u00a0C, Bai\u00a0JC, Holmes\u00a0G et\u00a0al (2023) Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a\u00a0multicentre, prospective cohort study. Lancet Gastroenterol Hepatol 8:1005\u20131014","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1842_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.gastro.2024.02.050","volume":"167","author":"V Discepolo","year":"2024","unstructured":"Discepolo\u00a0V, Kelly\u00a0CP, Koning\u00a0F et\u00a0al (2024) How future pharmacologic therapies for celiac disease will complement the gluten-free diet. Gastroenterology 167:90\u2013103","journal-title":"Gastroenterology"},{"key":"1842_CR7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1055\/a-1741-5946","volume":"60","author":"J Felber","year":"2022","unstructured":"Felber\u00a0J, Blaker\u00a0H, Fischbach\u00a0W et\u00a0al (2022) AktualisierteS2k-Leitlinie Z\u00f6liakie der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungsund Stoffwechselkrankheiten (DGVS). Z\u00a0Gastroenterol 60:790\u2013856","journal-title":"Z Gastroenterol"},{"key":"1842_CR8","doi-asserted-by":"crossref","unstructured":"Galipeau HJ, Hinterleitner R, Leonard MM et\u00a0al (2024) Non-Host Factors Influencing Onset and Severity of Celiac Disease. Gastroenterology","DOI":"10.1053\/j.gastro.2024.01.030"},{"key":"1842_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/apt.17417","volume":"57","author":"M Garz\u00f3n-Benavides","year":"2023","unstructured":"Garz\u00f3n-Benavides\u00a0M, Ruiz-Carnicer \u00c1, Segura\u00a0V et\u00a0al (2023) Clinical utility of urinary gluten immunogenic peptides in the follow-up of patients with coeliac disease. Aliment Pharmacol Ther 57:993\u20131003","journal-title":"Aliment Pharmacol Ther"},{"key":"1842_CR10","first-page":"23","volume":"167","author":"S Gatti","year":"2024","unstructured":"Gatti\u00a0S, Rubio-Tapia\u00a0A, Makharia\u00a0G et\u00a0al (2024) Patient and community health global burden in a\u00a0world with more celiac disease. Gastroenterology 167:23\u201333","journal-title":"Gastroenterology"},{"key":"1842_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/00365521.2021.1899278","volume":"56","author":"AJ Karajamaki","year":"2021","unstructured":"Karajamaki\u00a0AJ, Taavela\u00a0J, Nielsen\u00a0C et\u00a0al (2021) Celiac disease antibody levels reflect duodenal mucosal damage but not clinical symptoms. Scand J Gastroenterol 56:514\u2013519","journal-title":"Scand J Gastroenterol"},{"key":"1842_CR12","first-page":"553","volume":"112","author":"MW Laass","year":"2015","unstructured":"Laass\u00a0MW, Schmitz\u00a0R, Uhlig\u00a0HH et\u00a0al (2015) The prevalence of celiac disease in children and adolescents in Germany. Dtsch Arztebl Int 112:553\u2013560","journal-title":"Dtsch Arztebl Int"},{"key":"1842_CR13","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1111\/apt.16912","volume":"56","author":"P Laurikka","year":"2022","unstructured":"Laurikka\u00a0P, Kivel\u00e4\u00a0L, Kurppa\u00a0K et\u00a0al (2022) Systemic consequences of coeliac disease. Aliment Pharmacol Ther 56:S64\u2013S72","journal-title":"Aliment Pharmacol Ther"},{"key":"1842_CR14","first-page":"132","volume":"167","author":"G Malamut","year":"2024","unstructured":"Malamut\u00a0G, Soderquist\u00a0CR, Bhagat\u00a0G et\u00a0al (2024) Advances in nonresponsive and refractory celiac disease. Gastroenterology 167:132\u2013147","journal-title":"Gastroenterology"},{"key":"1842_CR15","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1136\/gutjnl-2023-329751","volume":"72","author":"A Schiepatti","year":"2023","unstructured":"Schiepatti\u00a0A, Maimaris\u00a0S, Raju\u00a0SA et\u00a0al (2023) Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a\u00a0multicentre longitudinal cohort study and development of a\u00a0score to identify high-risk patients. Gut 72:2095\u20132102","journal-title":"Gut"},{"key":"1842_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2032441","volume":"385","author":"D Schuppan","year":"2021","unstructured":"Schuppan\u00a0D, M\u00e4ki\u00a0M, Lundin\u00a0KE et\u00a0al (2021) A randomized trial of a\u00a0transglutaminase 2 inhibitor for celiac disease. N\u00a0Engl J Med 385:35\u201345","journal-title":"N Engl J Med"},{"key":"1842_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S2352-4642(23)00232-8","volume":"8","author":"M Stahl","year":"2024","unstructured":"Stahl\u00a0M, Koletzko\u00a0S, Andren Aronsson\u00a0C et\u00a0al (2024) Coeliac disease: what can we learn from prospective studies about disease risk? Lancet Child Adolesc Health 8:63\u201374","journal-title":"Lancet Child Adolesc Health"},{"key":"1842_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/jpn3.12280","volume":"79","author":"H Szajewska","year":"2024","unstructured":"Szajewska\u00a0H, Shamir\u00a0R, Auricchio\u00a0R et\u00a0al (2024) Early diet and the risk of coeliac disease. An update 2024 position paper by the ESPGHAN special interest group on coeliac disease. J\u00a0Pediatr Gastroenterol Nutr 79:438\u2013445","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1842_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.gastro.2024.04.011","volume":"167","author":"EF Verdu","year":"2024","unstructured":"Verdu\u00a0EF, Green\u00a0PH (2024) Celiac Disease Moves Into the Current Era of Modern Medicine. Gastroenterology 167:1\u20133","journal-title":"Gastroenterology"},{"key":"1842_CR20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1053\/j.gastro.2017.06.002","volume":"153","author":"KJ Werkstetter","year":"2017","unstructured":"Werkstetter\u00a0KJ, Korponay-Szabo\u00a0IR, Popp\u00a0A et\u00a0al (2017) Accuracy in diagnosis of celiac disease without biopsies in clinical practice. Gastroenterology 153:924\u2013935","journal-title":"Gastroenterology"},{"key":"1842_CR21","doi-asserted-by":"crossref","unstructured":"Wieser H, Amato M, Caggiano M et\u00a0al (2023) Dental Manifestations and Celiac Disease\u2014An Overview. J\u00a0Clin Med 12:","DOI":"10.3390\/jcm12082801"},{"key":"1842_CR22","doi-asserted-by":"crossref","unstructured":"Ylonen V, Lindfors K, Repo M et\u00a0al (2020) Non-Biopsy Serology-Based Diagnosis of Celiac Disease in Adults Is Accurate with Different Commercial Kits and Pre-Test Probabilities. Nutrients 12:","DOI":"10.3390\/nu12092736"},{"key":"1842_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.gastro.2024.02.044","volume":"167","author":"F Zingone","year":"2024","unstructured":"Zingone\u00a0F, Bai\u00a0JC, Cellier\u00a0C et\u00a0al (2024) Celiac disease-related conditions: who to test? Gastroenterology 167:64\u201378","journal-title":"Gastroenterology"},{"key":"1842_CR24","unstructured":"Letzter Zugriff: 12.12.2024. https:\/\/celiacfacts-onlinecourses.eu\/mod\/lesson\/view.php?id=824&pageid=335&startlastseen=yes"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01842-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01842-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01842-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:50:41Z","timestamp":1738752641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01842-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01842-9","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"13 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.P.\u00a0T\u00f6r\u00f6k gibt Beratungshonorare von Calypso Biontech und Immunic an und Zuwendungen zur Teilnahme an klinischen Studien im Bereich Z\u00f6liakie von Falk und Takeda Pharma. S.\u00a0Koletzko gibt Beratungshonorare von Takeda und Tillotts Pharma im Bereich Z\u00f6liakie an.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}